semaglutide patient information pdf 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial glp1 and semaglutide Semaglutide GLP-1

Mazdutide (IBI362): The Balanced Optimizers Mazdutide is often described as a mammalian analogue of oxyntomodulina naturally occurring hormone that activates both GLP-1 and Glucagon receptors

If both medications are used, the goal should be to balance benefits without increasing the risk of side effects

My period also skipped, because of the rapid weight loss (this happened the summer I lost 10 lbs in 6 weeks naturally too)

According to Grand View Research, specifically for GLP-1 weight-loss, the market size in 2025 is about $20.86 billion, expected to grow to $48.84 billion by 2030, with a CAGR of ~18.5%

doi: 10.1016/j.jpeds.2014.09.019 30 De LenDDLiCDelsonMIMatschiskyFMStanleyCAStoffersDA